HK1026212A1 - New indian-1-ol compounds, a process for their preparation and pharmaceutical compositions containing them - Google Patents

New indian-1-ol compounds, a process for their preparation and pharmaceutical compositions containing them

Info

Publication number
HK1026212A1
HK1026212A1 HK00105538A HK00105538A HK1026212A1 HK 1026212 A1 HK1026212 A1 HK 1026212A1 HK 00105538 A HK00105538 A HK 00105538A HK 00105538 A HK00105538 A HK 00105538A HK 1026212 A1 HK1026212 A1 HK 1026212A1
Authority
HK
Hong Kong
Prior art keywords
compounds
alkyl
preparation
pharmaceutical compositions
compositions containing
Prior art date
Application number
HK00105538A
Other languages
English (en)
Inventor
Jean-Louis Peglion
Bertrand Goument
Mark Millan
Adrian Newman-Tancredi
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of HK1026212A1 publication Critical patent/HK1026212A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
HK00105538A 1998-08-21 2000-09-04 New indian-1-ol compounds, a process for their preparation and pharmaceutical compositions containing them HK1026212A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9810601A FR2782515B1 (fr) 1998-08-21 1998-08-21 NOUVEAUX DERIVES DE L'INDANE-1-Ol, LEUR PROCEDE DE PREPARATION ET LES COMPOSITIONS PHARMACEUTIQUES QUI LES CONTIENNENT

Publications (1)

Publication Number Publication Date
HK1026212A1 true HK1026212A1 (en) 2000-12-08

Family

ID=9529811

Family Applications (1)

Application Number Title Priority Date Filing Date
HK00105538A HK1026212A1 (en) 1998-08-21 2000-09-04 New indian-1-ol compounds, a process for their preparation and pharmaceutical compositions containing them

Country Status (19)

Country Link
US (1) US6153625A (de)
EP (1) EP0982305B1 (de)
JP (1) JP2000072748A (de)
CN (1) CN1128144C (de)
AT (1) ATE214064T1 (de)
AU (1) AU747494B2 (de)
BR (1) BR9903867A (de)
CA (1) CA2280596A1 (de)
DE (1) DE69900961T2 (de)
DK (1) DK0982305T3 (de)
ES (1) ES2172294T3 (de)
FR (1) FR2782515B1 (de)
HK (1) HK1026212A1 (de)
HU (1) HUP9902784A3 (de)
NO (1) NO317516B1 (de)
NZ (1) NZ337362A (de)
PL (1) PL194852B1 (de)
PT (1) PT982305E (de)
ZA (1) ZA995321B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL156602A0 (en) * 2001-01-16 2004-01-04 Astrazeneca Ab Therapeutic chromone compounds
BR0206512A (pt) * 2001-01-16 2004-01-06 Astrazeneca Ab Composto, método de tratamento de um ser humano ou animal que sofre de depressão, ansiedade generalizada, distúrbios da alimentação, demência, distúrbio do p nico, distúrbios do sono, distúrbios gastrointestinais, distúrbios motores, distúrbios endócrinos, vasoespasmo e disfunção sexual, uso de um composto, e, processo para preparar um composto.
SE0103647D0 (sv) * 2001-11-01 2001-11-01 Astrazeneca Ab Therapeutic chromone compounds
SE0103646D0 (sv) * 2001-11-01 2001-11-01 Astrazeneca Ab Therapeutic chroman compounds
IL156601A0 (en) * 2001-01-16 2004-01-04 Astrazeneca Ab Therapeutic chroman compounds
DE10142662B4 (de) * 2001-08-31 2004-07-08 Aventis Pharma Deutschland Gmbh Derivate von C2-substituierten Indan-1-ol-Systemen und ihre Verwendung als Arzneimittel
DE10142661B4 (de) 2001-08-31 2004-06-09 Aventis Pharma Deutschland Gmbh Mehrfach substituierte Indan-1-ol-Systeme und ihre Verwendung als Arzneimittel
DE10142667B4 (de) * 2001-08-31 2004-06-09 Aventis Pharma Deutschland Gmbh C2-substituierte Indan-1-ole und ihre Derivate und ihre Verwendung als Arzneimittel
UY29892A1 (es) * 2005-11-04 2007-06-29 Astrazeneca Ab Nuevos derivados de cromano, composiciones farmaceuticas conteniendolos, procesos de preparacion y aplicaciones

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2681325B1 (fr) * 1991-09-16 1993-12-17 Fabre Medicament Pierre Derives de l'aminomethyl-4 piperidine, leur preparation et leur application en therapeutique.
GB9318431D0 (en) * 1993-09-06 1993-10-20 Boots Co Plc Therapeutic agents
FR2761358B1 (fr) * 1997-03-27 1999-05-07 Adir Nouveaux composes de n-aryl piperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
ZA995321B (en) 2000-02-22
FR2782515A1 (fr) 2000-02-25
US6153625A (en) 2000-11-28
NO994041D0 (no) 1999-08-20
PL194852B1 (pl) 2007-07-31
FR2782515B1 (fr) 2000-09-22
ES2172294T3 (es) 2002-09-16
HU9902784D0 (en) 1999-10-28
ATE214064T1 (de) 2002-03-15
NO317516B1 (no) 2004-11-08
PT982305E (pt) 2002-07-31
CN1250051A (zh) 2000-04-12
BR9903867A (pt) 2000-09-05
JP2000072748A (ja) 2000-03-07
AU4463799A (en) 2000-03-09
AU747494B2 (en) 2002-05-16
DE69900961D1 (de) 2002-04-11
PL335012A1 (en) 2000-02-28
EP0982305A1 (de) 2000-03-01
NO994041L (no) 2000-02-22
HUP9902784A2 (hu) 2000-12-28
EP0982305B1 (de) 2002-03-06
HUP9902784A3 (en) 2001-03-28
NZ337362A (en) 2000-04-28
DE69900961T2 (de) 2002-11-07
DK0982305T3 (da) 2002-06-24
CN1128144C (zh) 2003-11-19
CA2280596A1 (fr) 2000-02-21

Similar Documents

Publication Publication Date Title
NZ505453A (en) Hypolipidemic benzothiazepine compounds
SE9903998D0 (sv) New compounds
ATE296826T1 (de) Pyrazolo(1,5)pyridinderivate
PT1263725E (pt) Novos compostos
TR200001973T2 (tr) 11 ß-halojen-7alfa-ile ikame edilmiş-estratrienler, bu 11ß-halojen-7alfa-ile ikame edilmiş-estratrienleri içeren farmasötik terkiplerin üretimi için yöntem ve ilaç üretiminde kullanımları.
PH23607A (en) Amide derivatives and pharmaceutical composition containing said compounds
MXPA04000577A (es) Derivados de dolastatina 10.
ATE316083T1 (de) Adamantanderivate
HUP0400250A2 (hu) 5-HT6 és/vagy 5-HT7 szerotonin receptorok ligandumaként alkalmazott 5-halogén-triptamin-származékok, előállításuk és alkalmazásuk gyógyszerkészítmények előállítására
ATE300541T1 (de) Pyrazolopyridinderivate
SE9903997D0 (sv) New compounds
HK1026212A1 (en) New indian-1-ol compounds, a process for their preparation and pharmaceutical compositions containing them
HUP9902199A1 (hu) Új nitronszármazékok, ezek előállítási eljárása és ezeket tartalmazó gyógyszerkészítmények
DE60201074D1 (en) Pyrazolopyridinderivate
MXPA05010783A (es) Derivados antimicrobianos de [3.1.0] biciclohexilfenil-oxazolidinona y analogos.
AU2002357740A1 (en) Pyrazolo-pyridine derivatives as antiherpes agents
BG105923A (en) Novel morpholine derivatives, method for the production thereof and pharmaceutical preparations containing said derivatives
BG105794A (en) (1-phenacy-3-phenyl-3-piperidylethyl)piperidine derivatives, method for the production thereof and pharmaceutical compositions contaning the same
BR0013375A (pt) Composições farmacêuticas contendo derivados tiazolidinodiona e processo para sua preparação
SE9903996D0 (sv) New compounds
IL70557A (en) 4-(1-phenyl-1-hydroxypropyl)-resorcin derivatives,their preparation and pharmaceutical compositions containing them
HUP0002715A2 (hu) Benzotiofénszármazékok alkalmazása trombocitaszám csökkentésére szolgáló gyógyszerkészítmények előállítására
HK1024244A1 (en) 8h-thieno-(2,3-b)pyrrolizin-8-one compounds, a process for their preir preparation and pharmaceutical compositions containing them
ES8506702A1 (es) Un derivado del acido furiloxazolilacetico
HUP9801451A2 (hu) Tetrahidroimidazo[2,1-a]izokinolin-származékok és ezeket tartalmazó gyógyszerkészítmények, alkalmazásuk

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20080820